These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 38676691)
1. [A case of COVID-associated encephalopathy in a patient with multiple sclerosis]. Kuzmina US; Tukhvatullin AV; Lyutov OV; Talipova ID; Zakirova EN; Rakhmatullin AR; Kutlubaev MA; Bakhtiyarova KZ Zh Nevrol Psikhiatr Im S S Korsakova; 2024; 124(4):159-163. PubMed ID: 38676691 [TBL] [Abstract][Full Text] [Related]
2. Encephalopathy associated with COVID-19 in a patient with multiple sclerosis. Naser Moghadasi A J Neurovirol; 2020 Dec; 26(6):973-975. PubMed ID: 33118141 [TBL] [Abstract][Full Text] [Related]
3. Encephalopathy and COVID-19: a case report. Lazraq M; Benhamza S; Saadaoui S; Hayar S; Louardi M; Moujahid H; Bensaid A; Miloudi Y; Harrar NE Pan Afr Med J; 2021; 38():139. PubMed ID: 33912309 [TBL] [Abstract][Full Text] [Related]
4. [Clinical characteristics and short-term prognosis of 22 cases with SARS-CoV-2 infection associated acute encephalopathy]. Ren CH; Yang XY; Liu ZM; Zhuo XW; Han XD; Dai LF; Tian XJ; Feng WX; Ge L; Han TL; Chen CH; Fang F Zhonghua Er Ke Za Zhi; 2023 Jun; 61(6):543-549. PubMed ID: 37312467 [No Abstract] [Full Text] [Related]
5. Neurological manifestations associated with SARS-CoV-2 and other coronaviruses: A narrative review for clinicians. Maury A; Lyoubi A; Peiffer-Smadja N; de Broucker T; Meppiel E Rev Neurol (Paris); 2021; 177(1-2):51-64. PubMed ID: 33446327 [TBL] [Abstract][Full Text] [Related]
7. Encephalopathy in patients with COVID-19: A review. Garg RK; Paliwal VK; Gupta A J Med Virol; 2021 Jan; 93(1):206-222. PubMed ID: 32558956 [TBL] [Abstract][Full Text] [Related]
8. A Case of Multiple Sclerosis with Protracted Course of COVID-19. Hasibi M; Asadollahi M; Asadollahi-Amin A Infect Disord Drug Targets; 2022; 22(4):e280122200652. PubMed ID: 35088680 [TBL] [Abstract][Full Text] [Related]
9. A young man presenting with encephalopathy and seizures secondary to SARS-CoV-2. Jalil BA; Ijaz M; Khan AM; Ledbetter TG BMJ Case Rep; 2021 Mar; 14(3):. PubMed ID: 33762283 [TBL] [Abstract][Full Text] [Related]
12. Three-tier stratification for CNS COVID-19 to help decide which patients should undergo lumbar puncture with CSF analysis: a case report and literature review. Ramakrishna JM; Libertin CR; Siegel J; Binnicker MJ; Harris D; Matcha GV; Caulfield T; Freeman WD Rom J Intern Med; 2021 Mar; 59(1):88-92. PubMed ID: 33098636 [TBL] [Abstract][Full Text] [Related]
13. Acute cerebellitis following SARS-CoV-2 infection: A case report and review of the literature. Moreno-Escobar MC; Feizi P; Podury S; Tandon M; Munir B; Alvi M; Adcock A; Sriwastava S J Med Virol; 2021 Dec; 93(12):6818-6821. PubMed ID: 34314031 [TBL] [Abstract][Full Text] [Related]
14. Negative SARS-CoV-2 antibody testing following COVID-19 infection in Two MS patients treated with ocrelizumab. Thornton JR; Harel A Mult Scler Relat Disord; 2020 Sep; 44():102341. PubMed ID: 32622338 [TBL] [Abstract][Full Text] [Related]
15. Asymptomatic SARS-CoV-2 infection in two patients with multiple sclerosis treated with fingolimod. Mallucci G; Zito A; Fabbro BD; Bergamaschi R Mult Scler Relat Disord; 2020 Oct; 45():102414. PubMed ID: 32711296 [No Abstract] [Full Text] [Related]
16. Safety of disease-modifying treatments in SARS-CoV-2 antibody-positive multiple sclerosis patients. Mallucci G; Zito A; Baldanti F; Gastaldi M; Fabbro BD; Franciotta D; Bergamaschi R Mult Scler Relat Disord; 2021 Apr; 49():102754. PubMed ID: 33609958 [TBL] [Abstract][Full Text] [Related]
17. A rare, treatable cause of relapsing encephalopathy in an MS patient on interferon beta therapy. Polman CH; Jansen PH; Jansen C; Uitdehaag BM Neurology; 2003 Sep; 61(5):719. PubMed ID: 12963780 [No Abstract] [Full Text] [Related]
18. Hyponatremia and Encephalopathy in a 55-Year-old Woman with Syndrome of Inappropriate Antidiuretic Hormone Secretion as an Isolated Presentation of SARS-CoV-2 Infection. Sherazi A; Bedi P; Udevbulu E; Rubin V; Alasadi L; Spitalewitz S Am J Case Rep; 2021 Mar; 22():e930135. PubMed ID: 33760803 [TBL] [Abstract][Full Text] [Related]
19. Seroconversion and indolent course of COVID-19 in patients with multiple sclerosis treated with fingolimod and teriflunomide. Bollo L; Guerra T; Bavaro DF; Monno L; Saracino A; Angarano G; Paolicelli D; Trojano M; Iaffaldano P J Neurol Sci; 2020 Sep; 416():117011. PubMed ID: 32650143 [No Abstract] [Full Text] [Related]